340 related articles for article (PubMed ID: 24658816)
1. The erythroid function of transferrin receptor 2 revealed by Tmprss6 inactivation in different models of transferrin receptor 2 knockout mice.
Nai A; Pellegrino RM; Rausa M; Pagani A; Boero M; Silvestri L; Saglio G; Roetto A; Camaschella C
Haematologica; 2014 Jun; 99(6):1016-21. PubMed ID: 24658816
[TBL] [Abstract][Full Text] [Related]
2. Severe microcytic anemia but increased erythropoiesis in mice lacking Hfe or Tfr2 and Tmprss6.
Lee P; Hsu MH; Welser-Alves J; Peng H
Blood Cells Mol Dis; 2012 Mar; 48(3):173-8. PubMed ID: 22244935
[TBL] [Abstract][Full Text] [Related]
3. A critical role for murine transferrin receptor 2 in erythropoiesis during iron restriction.
Wallace DF; Secondes ES; Rishi G; Ostini L; McDonald CJ; Lane SW; Vu T; Hooper JD; Velasco G; Ramsay AJ; Lopez-Otin C; Subramaniam VN
Br J Haematol; 2015 Mar; 168(6):891-901. PubMed ID: 25403101
[TBL] [Abstract][Full Text] [Related]
4. Global loss of Tfr2 with concomitant induced iron deficiency greatly ameliorates the phenotype of a murine thalassemia intermedia model.
Schmidt PJ; Fitzgerald K; Butler JS; Fleming MD
Am J Hematol; 2021 Feb; 96(2):251-257. PubMed ID: 33180328
[TBL] [Abstract][Full Text] [Related]
5. Retinal expression of the serine protease matriptase-2 (Tmprss6) and its role in retinal iron homeostasis.
Gnana-Prakasam JP; Baldowski RB; Ananth S; Martin PM; Smith SB; Ganapathy V
Mol Vis; 2014; 20():561-74. PubMed ID: 24791141
[TBL] [Abstract][Full Text] [Related]
6. Extrahepatic deficiency of transferrin receptor 2 is associated with increased erythropoiesis independent of iron overload.
Wortham AM; Goldman DC; Chen J; Fleming WH; Zhang AS; Enns CA
J Biol Chem; 2020 Mar; 295(12):3906-3917. PubMed ID: 32054685
[TBL] [Abstract][Full Text] [Related]
7. Correcting β-thalassemia by combined therapies that restrict iron and modulate erythropoietin activity.
Casu C; Pettinato M; Liu A; Aghajan M; Lo Presti V; Lidonnici MR; Munoz KA; O'Hara E; Olivari V; Di Modica SM; Booten S; Guo S; Neil G; Miari R; Shapir N; Zafir-Lavie I; Domev H; Ferrari G; Sitara D; Nai A; Rivella S
Blood; 2020 Oct; 136(17):1968-1979. PubMed ID: 32556142
[TBL] [Abstract][Full Text] [Related]
8. Comparison of 3 Tfr2-deficient murine models suggests distinct functions for Tfr2-alpha and Tfr2-beta isoforms in different tissues.
Roetto A; Di Cunto F; Pellegrino RM; Hirsch E; Azzolino O; Bondi A; Defilippi I; Carturan S; Miniscalco B; Riondato F; Cilloni D; Silengo L; Altruda F; Camaschella C; Saglio G
Blood; 2010 Apr; 115(16):3382-9. PubMed ID: 20179178
[TBL] [Abstract][Full Text] [Related]
9. Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice.
Nai A; Rubio A; Campanella A; Gourbeyre O; Artuso I; Bordini J; Gineste A; Latour C; Besson-Fournier C; Lin HY; Coppin H; Roth MP; Camaschella C; Silvestri L; Meynard D
Blood; 2016 May; 127(19):2327-36. PubMed ID: 26755707
[TBL] [Abstract][Full Text] [Related]
10. The second transferrin receptor regulates red blood cell production in mice.
Nai A; Lidonnici MR; Rausa M; Mandelli G; Pagani A; Silvestri L; Ferrari G; Camaschella C
Blood; 2015 Feb; 125(7):1170-9. PubMed ID: 25499454
[TBL] [Abstract][Full Text] [Related]
11. The extrahepatic role of TFR2 in iron homeostasis.
Silvestri L; Nai A; Pagani A; Camaschella C
Front Pharmacol; 2014; 5():93. PubMed ID: 24847265
[TBL] [Abstract][Full Text] [Related]
12. Tmprss6 is a genetic modifier of the Hfe-hemochromatosis phenotype in mice.
Finberg KE; Whittlesey RL; Andrews NC
Blood; 2011 Apr; 117(17):4590-9. PubMed ID: 21355094
[TBL] [Abstract][Full Text] [Related]
13. An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-/-) mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia.
Schmidt PJ; Toudjarska I; Sendamarai AK; Racie T; Milstein S; Bettencourt BR; Hettinger J; Bumcrot D; Fleming MD
Blood; 2013 Feb; 121(7):1200-8. PubMed ID: 23223430
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic deletion of transferrin receptor 2 in mice leads to a block in erythroid differentiation during iron-deficient anemia.
Rishi G; Secondes ES; Wallace DF; Subramaniam VN
Am J Hematol; 2016 Aug; 91(8):812-8. PubMed ID: 27169626
[TBL] [Abstract][Full Text] [Related]
15. Matriptase-2 suppresses hepcidin expression by cleaving multiple components of the hepcidin induction pathway.
Wahedi M; Wortham AM; Kleven MD; Zhao N; Jue S; Enns CA; Zhang AS
J Biol Chem; 2017 Nov; 292(44):18354-18371. PubMed ID: 28924039
[TBL] [Abstract][Full Text] [Related]
16. Disruption of hemochromatosis protein and transferrin receptor 2 causes iron-induced liver injury in mice.
Delima RD; Chua AC; Tirnitz-Parker JE; Gan EK; Croft KD; Graham RM; Olynyk JK; Trinder D
Hepatology; 2012 Aug; 56(2):585-93. PubMed ID: 22383097
[TBL] [Abstract][Full Text] [Related]
17. Iron regulation of hepcidin despite attenuated Smad1,5,8 signaling in mice without transferrin receptor 2 or Hfe.
Corradini E; Rozier M; Meynard D; Odhiambo A; Lin HY; Feng Q; Migas MC; Britton RS; Babitt JL; Fleming RE
Gastroenterology; 2011 Nov; 141(5):1907-14. PubMed ID: 21745449
[TBL] [Abstract][Full Text] [Related]
18. Transgenic HFE-dependent induction of hepcidin in mice does not require transferrin receptor-2.
Schmidt PJ; Fleming MD
Am J Hematol; 2012 Jun; 87(6):588-95. PubMed ID: 22460705
[TBL] [Abstract][Full Text] [Related]
19. TMPRSS6, but not TF, TFR2 or BMP2 variants are associated with increased risk of iron-deficiency anemia.
An P; Wu Q; Wang H; Guan Y; Mu M; Liao Y; Zhou D; Song P; Wang C; Meng L; Man Q; Li L; Zhang J; Wang F
Hum Mol Genet; 2012 May; 21(9):2124-31. PubMed ID: 22323359
[TBL] [Abstract][Full Text] [Related]
20. Interaction of the hereditary hemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression.
Gao J; Chen J; Kramer M; Tsukamoto H; Zhang AS; Enns CA
Cell Metab; 2009 Mar; 9(3):217-27. PubMed ID: 19254567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
